M6PR

Cation-dependent mannose-6-phosphate receptor · P20645 · M6PR on Sugi Atlas →

499 patent compounds predicted against M6PR, 94 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL8615533 SCHEMBL8615533 0.56 2/20
SCHEMBL15698043 SCHEMBL15698043 0.56 2/20
SCHEMBL15700171 SCHEMBL15700171 0.56 2/20
SCHEMBL19502333 SCHEMBL19502333 0.56 2/20
SCHEMBL20143964 SCHEMBL20143964 0.56 2/20
SCHEMBL4329591 SCHEMBL4329591 0.51 2/20
SCHEMBL16093664 SCHEMBL16093664 0.51 2/20
SCHEMBL16098706 SCHEMBL16098706 0.51 2/20
SCHEMBL1772063 SCHEMBL1772063 0.50 2/20
SCHEMBL714447 SCHEMBL714447 0.44 2/20
SCHEMBL767063 SCHEMBL767063 0.44 2/20
SCHEMBL767128 SCHEMBL767128 0.44 2/20
SCHEMBL1004728 SCHEMBL1004728 0.44 2/20
SCHEMBL1007197 SCHEMBL1007197 0.44 2/20
SCHEMBL1832193 SCHEMBL1832193 0.44 2/20
SCHEMBL1919200 SCHEMBL1919200 0.44 2/20
SCHEMBL2233716 SCHEMBL2233716 0.44 2/20
SCHEMBL2502348 SCHEMBL2502348 0.44 2/20
SCHEMBL2505909 SCHEMBL2505909 0.44 2/20
SCHEMBL2743468 SCHEMBL2743468 0.44 2/20

Clinical trials — most relevant to M6PR by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus PHASE4UNKNOWN
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma PHASE3COMPLETED
D Mannose in Recurrent Urinary Tract Infections PHASE3COMPLETED
Diabetic Retinopathy Sulodexide Study PHASE2COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) PHASE2COMPLETED
First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers PHASE1COMPLETED
ERT in Pompe Disease: Elucidation of Molecular Structures Contributing to Enzyme Uptake and Immunoreactivity nanUNKNOWN
Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans nanCOMPLETED
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
The Natural History of Alpha-Mannosidosis nanCOMPLETED
International Milk Composition (IMiC) Consortium nanACTIVE_NOT_RECRUITING
Cell Distribution in Induced Sputum in Patients With Asthma nanCOMPLETED
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients nanCOMPLETED
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation nanUNKNOWN
Meteorin-like Levels in Individuals With Periodontitis nanCOMPLETED
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) nanUNKNOWN
The Clinical Diagnosis Meaning of MIF in Coronary Heart Disease nanCOMPLETED
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches nanUNKNOWN
Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis nanUNKNOWN
Biomarker for Mannosidosis Disease (BioMannosidosis) nanWITHDRAWN
Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance nanUNKNOWN
Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease nanCOMPLETED
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism nanNOT_YET_RECRUITING
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma nanSUSPENDED
Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin nanUNKNOWN
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Immune Profile and Complication Risk in Type 2 Diabetes nanUNKNOWN
Effect of Preoperative Music on Sterile Inflammation Induced by Laparoscopic Surgery nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a M6PR binder may also engage these)

ProteinNameSimilarity
P11456 1.000 P11456 →
P24668 1.000 P24668 →
Q6AY20 0.998 Q6AY20 →
Q5R8S4 0.970 Q5R8S4 →
A8WCC4 0.970 A8WCC4 →
Q8VEH8 0.970 Q8VEH8 →
CSGALNACT1 Chondroitin sulfate N-acetylgalactosaminyltransferase 1 0.967 landscape →
A8MWY0 0.967 A8MWY0 →
Q9NRA1 0.967 Q9NRA1 →
Q9EQX6 0.966 Q9EQX6 →
Q8BJQ9 0.966 Q8BJQ9 →
A7E2Z9 0.966 A7E2Z9 →
Q3UZV7 0.965 Q3UZV7 →
Q8NFZ0 0.965 Q8NFZ0 →
Q8R143 0.965 Q8R143 →
Q66H91 0.964 Q66H91 →
Q8C1F4 0.964 Q8C1F4 →
Q6PCX7 0.963 Q6PCX7 →
Q0VBD0 0.963 Q0VBD0 →
O13097 0.963 O13097 →
Q6NRQ1 0.962 Q6NRQ1 →
Q9I946 0.962 Q9I946 →
Q8CI19 0.962 Q8CI19 →
O94985 0.962 O94985 →
Q8N6G5 0.962 Q8N6G5 →
O73874 0.962 O73874 →
O73753 0.962 O73753 →
MAP3K20 Mitogen-activated protein kinase kinase kinase 20 0.962 landscape →
D4A6L0 0.961 D4A6L0 →
HLCS Biotin--protein ligase 0.961 landscape →